Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Trial details
- Registry ID
- NCT07457918
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)NCT07457918 | VRCA | Phase 3 | Recruiting | 2027-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |